Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luoyang Desheng Bio-Tech is a private Chinese manufacturer of pharmaceutical intermediates and active pharmaceutical ingredient-related purine products based in Luoyang, Henan. The company appears to have operated since 2005 and has also been referred to historically as Luoyang Desheng Chemical. Its business is centered on the research, manufacture, and sale of purine and nucleoside-related products such as adenine, adenine sulfate, adenine phosphate, hypoxanthine, and 6-chloropurine, which are sold as pharmaceutical intermediates and biochemical products rather than branded therapeutics. Available public information suggests the company maintains in-house R&D, quality testing, and manufacturing capabilities and exports to markets including Japan, India, Indonesia, and the United States. It should be viewed primarily as a commercial API/intermediate supplier rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luoyang Dengsheng.